Matsushita et al. (2021) demonstrated that SCFA-induced IGF-1 production from gut bacteria influences prostate cancer growth by activating local prostate MAPK and PI3K signaling pathways, thereby suggesting the existence of a gut microbiota-IGF-1-prostate axis. The gene discussed is IGF1; the disease is prostate carcinoma.